Media coverage about Therapix Biosciences Ltd. – American Depositary Shares (NASDAQ:TRPX) has been trending somewhat positive on Thursday, Accern Sentiment reports. Accern identifies negative and positive press coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Therapix Biosciences Ltd. – American Depositary Shares earned a news impact score of 0.15 on Accern’s scale. Accern also gave news articles about the company an impact score of 46.8780337933731 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

Therapix Biosciences Ltd. – American Depositary Shares (TRPX) opened at $5.24 on Thursday. Therapix Biosciences Ltd. – American Depositary Shares has a 52-week low of $4.26 and a 52-week high of $10.95.

ILLEGAL ACTIVITY WARNING: This report was originally reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this report on another site, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this report can be viewed at https://www.thecerbatgem.com/2017/12/21/therapix-biosciences-ltd-american-depositary-shares-trpx-receiving-somewhat-favorable-press-coverage-study-shows.html.

About Therapix Biosciences Ltd. – American Depositary Shares

Therapix Biosciences Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. Its drug development programs include Joint Pharma that develops THX-TS01 for the treatment of Tourette Syndrome (TS); and BrainBright Pharma, which develops THX-ULD01, a drug candidate based on an ultra-low dose of dronabinol for the treatment for mild cognitive impairment.

Insider Buying and Selling by Quarter for Therapix Biosciences Ltd. - American Depositary Shares (NASDAQ:TRPX)

Receive News & Ratings for Therapix Biosciences Ltd. - American Depositary Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Therapix Biosciences Ltd. - American Depositary Shares and related companies with MarketBeat.com's FREE daily email newsletter.